Rosette formation in Hodgkin's disease.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000276:immunology*; D006801:Humans; D007104:Immune Adherence Reaction; D007111:Immunity, Cellular; D007958:Leukocyte Count; D008297:Male; D012075:Remission, Spontaneous; D013601:T-Lymphocytes / Q000276:immunology*
D000970:Antineoplastic Agents